Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia. |
In vivo | On a normal diet, beclobrate lowered total plasma cholesterol levels by 22-33.4% (10-50 mg/kg), the reduction in cholesterol occurred mainly in high-density lipoproteins (HDL), with a decrease of 24-45% at the three tested doses[1]. |
Synonyms | Sgd 24774 |
Molecular Weight | 346.85 |
Formula | C20H23ClO3 |
CAS No. | 55937-99-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Beclobrate 55937-99-0 Others Sgd 24774 inhibitor inhibit